BSE Live
Jan 20, 14:41Prev. Close
1391.20
Open Price
1392.15
Bid Price (Qty.)
1382.65 (6)
Offer Price (Qty.)
1383.30 (16)
NSE Live
Jan 20, 14:41Prev. Close
1392.30
Open Price
1392.30
Bid Price (Qty.)
1382.20 (7)
Offer Price (Qty.)
1382.70 (293)
| Profit & Loss account of Cipla (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 12,220.22 | 11,968.44 | 11,004.44 | 10,637.08 | 11,873.46 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 54.91 | 206.09 | 0.00 | |
| Revenue From Operations [Net] | 12,220.22 | 11,968.44 | 10,949.53 | 10,430.99 | 11,873.46 | |
| Total Operating Revenues | 12,659.15 | 12,374.01 | 11,389.90 | 10,768.49 | 12,117.72 | |
| Other Income | 892.85 | 577.52 | 334.88 | 129.85 | 280.30 | |
| Total Revenue | 13,552.00 | 12,951.53 | 11,724.78 | 10,898.34 | 12,398.02 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 2,999.17 | 3,112.25 | 3,303.31 | 2,956.04 | 3,633.34 | |
| Purchase Of Stock-In Trade | 1,363.12 | 1,259.21 | 1,064.23 | 1,128.99 | 1,037.56 | |
| Operating And Direct Expenses | 0.00 | 0.00 | 475.13 | 443.37 | 0.00 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -43.08 | 136.70 | -212.05 | 56.27 | 228.35 | |
| Employee Benefit Expenses | 1,911.08 | 1,839.84 | 1,785.94 | 1,728.97 | 1,778.56 | |
| Finance Costs | 36.05 | 16.97 | 11.90 | 39.20 | 147.07 | |
| Depreciation And Amortisation Expenses | 599.78 | 569.72 | 529.61 | 499.97 | 442.69 | |
| Other Expenses | 3,721.57 | 3,524.01 | 2,777.79 | 2,858.59 | 3,386.48 | |
| Total Expenses | 10,587.69 | 10,458.70 | 9,735.86 | 9,711.40 | 10,654.05 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 2,964.31 | 2,492.83 | 1,988.92 | 1,186.94 | 1,743.97 | |
| Exceptional Items | 0.00 | 0.00 | -77.52 | 0.00 | 0.00 | |
| Profit/Loss Before Tax | 2,964.31 | 2,492.83 | 1,911.40 | 1,186.94 | 1,743.97 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 545.96 | 576.43 | 431.33 | 311.06 | 356.64 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax | 100.18 | 27.99 | 11.55 | -99.06 | -74.97 | |
| Tax For Earlier Years | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Tax Expenses | 646.14 | 604.42 | 442.88 | 212.00 | 281.67 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 2,318.17 | 1,888.41 | 1,468.52 | 974.94 | 1,462.30 | |
| Profit/Loss From Continuing Operations | 2,318.17 | 1,888.41 | 1,468.52 | 974.94 | 1,462.30 | |
| Profit/Loss For The Period | 2,318.17 | 1,888.41 | 1,468.52 | 974.94 | 1,462.30 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | 28.76 | 23.45 | 18.25 | 12.13 | 18.21 | |
| Diluted EPS (Rs.) | 28.72 | 23.41 | 18.22 | 12.11 | 18.16 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 564.26 | 241.57 | 160.94 | 160.87 | 180.92 | |
| Tax On Dividend | 87.45 | 40.40 | 28.33 | 32.71 | 0.00 | |
| Equity Dividend Rate (%) | 200.00 | 150.00 | 150.00 | 100.00 | 100.00 |
08.01.2026
07.01.2026
Cipla shares slide 4.5% after USFDA flags compliance gaps at key Lanreotide supplier site
17.12.2025
11.12.2025
10.11.2025
Cipla Standalone September 2025 Net Sales at Rs 5,225.72 crore, up 9.44% Y-o-Y
03.11.2025
Cipla Consolidated September 2025 Net Sales at Rs 7,589.44 crore, up 7.64% Y-o-Y
25.07.2025
Cipla Standalone June 2025 Net Sales at Rs 5,046.17 crore, up 12.11% Y-o-Y
25.07.2025
Cipla Consolidated June 2025 Net Sales at Rs 6,957.47 crore, up 3.94% Y-o-Y
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
09.05.2024
17.04.2024
Cipla Q4 PAT may dip 24.9% YoY to Rs 869.4 cr: ICICI Securities
12.07.2023
28.01.2025
30.10.2024
Multiple near-term challenges may hijack Cipla's growth trajectory
13.05.2024
06.11.2018
Cipla down 5% on poor Q2, tough guidance ahead; Citi, HSBC downgrade ratings